- Home
- BWAY vs CADL Comparison
BWAY vs CADL Comparison
Compare BWAY & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- CADL
- Stock Information
- Founded
- BWAY 2003
- CADL 1999
- Country
- BWAY Israel
- CADL United States
- Employees
- BWAY N/A
- CADL N/A
- Industry
- BWAY Medical/Dental Instruments
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- BWAY Health Care
- CADL Health Care
- Exchange
- BWAY Nasdaq
- CADL Nasdaq
- Market Cap
- BWAY 207.4M
- CADL 234.8M
- IPO Year
- BWAY 2019
- CADL 2021
- Fundamental
- Price
- BWAY $8.76
- CADL $4.81
- Analyst Decision
- BWAY Strong Buy
- CADL Strong Buy
- Analyst Count
- BWAY 3
- CADL 4
- Target Price
- BWAY $13.17
- CADL $21.00
- AVG Volume (30 Days)
- BWAY 24.0K
- CADL 854.0K
- Earning Date
- BWAY 05-13-2025
- CADL 05-20-2025
- Dividend Yield
- BWAY N/A
- CADL N/A
- EPS Growth
- BWAY N/A
- CADL N/A
- EPS
- BWAY 0.06
- CADL N/A
- Revenue
- BWAY $41,016,000.00
- CADL N/A
- Revenue This Year
- BWAY $351.53
- CADL N/A
- Revenue Next Year
- BWAY $21.84
- CADL N/A
- P/E Ratio
- BWAY $57.37
- CADL N/A
- Revenue Growth
- BWAY 29.04
- CADL N/A
- 52 Week Low
- BWAY $5.13
- CADL $3.79
- 52 Week High
- BWAY $11.79
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- BWAY 47.80
- CADL 42.39
- Support Level
- BWAY $8.61
- CADL $4.34
- Resistance Level
- BWAY $9.09
- CADL $5.34
- Average True Range (ATR)
- BWAY 0.38
- CADL 0.33
- MACD
- BWAY 0.05
- CADL 0.10
- Stochastic Oscillator
- BWAY 58.73
- CADL 47.11
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.